Skip to main content

Table 5 Biomarker results

From: Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: a randomized, controlled clinical trial

 

0-week

20-week

Change over 20 weeks

Biomarker

Control

Intervention

Control

Intervention

Control

Intervention

p-value

Plasma AB42/40 Ratio

0.048

0.047

0.044

0.049

-0.004

0.003

0.003

Phosphorylated Tau181 (pTau181)

45.32

43.57

50.72

43.74

5.40

0.17

0.209

Insulin

9.50

8.68

8.21

6.77

-1.30

-1.92

0.048

Beta-Hydroxybutyrate (ketones)

0.11

0.09

0.06

0.11

-0.05

0.02

0.021

LDL cholesterol

1.91

1.93

1.95

1.32

0.04

-0.61

<0.001

Glial Fibrillary Acidic Protein (GFAP)

250.27

229.68

282.69

232.85

32.42

3.16

0.199

C-reactive Protein (CRP)

2.02

2.00

1.75

0.95

-0.27

-1.05

0.373

Serum amyloid A (SAA)

6.42

5.79

6.30

4.14

-0.12

-1.65

0.074

Glycoprotein acetylation (GlycA)

0.843

0.891

0.83

0.81

-0.01

-0.08

0.005

Telomere length

0.774

0.799

0.776

0.814

0.002

0.015

0.287